$Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction$

Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction

Abstract Aims The aim of this study was to elucidate the clinical characteristics, including frailty status, of patients with heart failure with preserved ejection fraction (HFpEF) in comparison with those in patients with heart failure with reduced ejection fraction (HFrEF) in a super‐aged region o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tomoyuki Hamada, Toru Kubo, Kazuya Kawai, Yoko Nakaoka, Toshikazu Yabe, Takashi Furuno, Eisuke Yamada, Hiroaki Kitaoka, Kochi YOSACOI study
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	ESC Heart Failure
Subjects:	Frailty Physical function Heart failure Heat failure with preserved ejection fraction Elderly
Online Access:	https://doi.org/10.1002/ehf2.13885
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction
by: Akihiro Sunaga, et al.
Published: (2022-06-01)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
by: Robert J.H. Miller, et al.
Published: (2022-06-01)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
by: Djawid Hashemi, et al.
Published: (2020-06-01)

Physical vs. multidimensional frailty in older adults with and without heart failure
by: Gianluca Testa, et al.
Published: (2020-06-01)

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
by: Enrique Santas, et al.
Published: (2020-06-01)

Clinical characteristics and outcomes in Asian patients with heart failure with mildly reduced ejection fraction
by: Julian Cheong Kiat Tay, et al.
Published: (2024-07-01)

Prevalence and prognostic impact of cognitive frailty in elderly patients with heart failure: sub‐analysis of FRAGILE‐HF
by: Shuhei Yamamoto, et al.
Published: (2022-06-01)

Electrocardiography-based artificial intelligence predicts the upcoming future of heart failure with mildly reduced ejection fraction
by: Dae-Young Kim, et al.
Published: (2025-02-01)

Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction
by: Anouk Achten, et al.
Published: (2025-04-01)

The simpler modified fried frailty scale predicts 2-year mortality in older adults with heart failure: a pilot study
by: Celalettin Küçük, et al.
Published: (2025-01-01)

Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity
by: Bas M. van Dalen, et al.
Published: (2025-02-01)

Efficacy of vericiguat in patients with chronic heart failure and reduced ejection fraction: a prospective observational study
by: Yinge Zhan, et al.
Published: (2025-02-01)

Frailty Assessment Tools in Chronic Kidney Disease: A Systematic Review and Meta-analysis
by: Alisha Puri, et al.
Published: (2025-03-01)

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study
by: Eiichi Akiyama, et al.
Published: (2020-06-01)

Temporal Trends in Mortality and Hospitalization Risk in Patients With Heart Failure According to the Hospital Frailty Risk Score
by: Noor K. Abassi, et al.
Published: (2025-02-01)

Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease
by: Seonhwa Lee, et al.
Published: (2020-06-01)

The relevance of a multidomain geriatric assessment in older patients with heart failure
by: Emma E.F. Kleipool, et al.
Published: (2020-06-01)

Hospital frailty risk score predicts graft failure severe infection and mortality in hospitalized kidney transplant recipients from 2010 to 2018 US data
by: Lumin Chen, et al.
Published: (2025-02-01)

Clinical study on the treatment of chronic heart failure with a novel D‐shant atrium shunt device
by: Xiaoke Shang, et al.
Published: (2022-06-01)

Chronic obstructive pulmonary disease and heart failure in real life: the tip of the iceberg in the sea of comorbidities. A prospective observational study
by: Ombretta Para, et al.
Published: (2025-02-01)

AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis
by: Wuping Tan, et al.
Published: (2025-02-01)

Safety and efficacy of catheter ablation in atrial fibrillation patients with heart failure with preserved ejection fraction
by: Songbing Long, et al.
Published: (2025-01-01)

Changes of the quality of life and efficiency criteria of coronary artery bypass grafting in patients with stable coronary artery disease and preserved left ventricular ejection fraction
by: Yu.A. Borkhalenko, et al.
Published: (2018-06-01)

Multi-organ frailty is enhanced by periodontitis-induced inflammaging
by: Yoshitaka Kase, et al.
Published: (2025-02-01)

Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial
by: Rolf Wachter, et al.
Published: (2020-06-01)

Sodium‐glucose cotransporter‐2 inhibitors in heart failure: an updated meta‐analysis
by: Yang Cao, et al.
Published: (2022-06-01)

Frailty in older adults admitted to hospital: outcomes from the Western Sydney Clinical Frailty Registry
by: Julee McDonagh, et al.
Published: (2025-02-01)

The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF)
by: Darshan Hullon, et al.
Published: (2025-02-01)

Impact of Initial Heart Rate, Diastolic Pressure, and Pulse Pressure on Prognostic Outcomes in Heart Failure Patients with Mildly Reduced Ejection Fraction
by: Hu H, et al.
Published: (2025-01-01)

Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care
by: Daniela Tomasoni, et al.
Published: (2022-06-01)

Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction
by: Shunsuke Tamaki, et al.
Published: (2020-06-01)

Global applications of the frailty index based on the deficit accumulation model
by: Xuemei Cai, et al.
Published: (2025-01-01)

Sacubitril/valsartan on right ventricular-pulmonary artery coupling and albumin-bilirubin score in heart failure in Chinese patients with reduced ejection fraction
by: Yanan Shi, et al.
Published: (2025-01-01)

Association of social frailty, sarcopenia, and oral frailty with depressive symptoms in Chinese older adults: a cross-sectional study
by: Yuanhao Sun, et al.
Published: (2025-02-01)

Association between insulin resistance indices and outcomes in patients with heart failure with preserved ejection fraction
by: Weicheng Ni, et al.
Published: (2025-01-01)

Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: a quantitative synthesis of the literature
by: Navkaranbir S. Bajaj, et al.
Published: (2020-06-01)

IMPROVING EFFICIENCY OF THE JET PUMP AT LOW COEFFICIENTS OF EJECTION
by: A. G. Butenko, et al.
Published: (2015-06-01)

Development of a psychological frailty index: results from the China health and retirement longitudinal study
by: Jinlong Zhao, et al.
Published: (2025-02-01)

Progress in Managing Heart Failure: an in-depth Review of Sacubitril/Valsartan Combination Therapy
by: Neeraj Hiremath, et al.
Published: (2024-04-01)

Post-Implant Global Longitudinal Strain as a Predictor of Pacing-Induced Cardiomyopathy in Patients with Preserved Ejection Fraction Undergoing Pacemaker Placement
by: Sung Soo Kim, et al.
Published: (2025-01-01)